China Resources Pharma Raises $1.8 Billion from IPO

Oct 24, 2016

Bloomberg

China Resources Pharmaceutical Group Ltd. raised $1.8 billion after pricing its initial public offering below the midpoint of a marketed range, according to a Bloomberg article.

The nation’s second-largest drug manufacturer is completing the biggest drugmaker IPO globally since 2013, when Zoetis Inc. priced a $2.6 billion U.S. offering, according Bloomberg data.

Backed by the state-owned conglomerate China Resources Holdings Co., the company manufactures Western pharmaceuticals, traditional Chinese medicine preparations and health supplements.

Read the Bloomberg story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments